IN8BIO, INC. — Form D
IN8BIO, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-30. The offering totals $40.2M, of which $20.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-30
- Form: D
- Accession: 0001231919-25-000676
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.2M
- Amount sold: $20.1M
- Remaining: $20.1M
- Investors: 17
- Date of first sale: 2025-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-568472
Issuer
- Name: IN8BIO, INC.
- CIK: 0001740279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: EMPIRE STATE BUILDING, NEW YORK, NY, 10118
- Phone: (646) 600-6438
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Peter S Brandt | Director | Colorado Springs, CO |
| Corinne R Epperly | Director | New York, NY |
| Emily R Fairbairn | Director | New York, NY |
| Jeremy R Graff | Director | New York, NY |
| Luba R Greenwood | Director | New York, NY |
| William Ho | Director | New York, NY |
| Alan S Roemer | Director | New York, NY |
| William Ho | Executive Officer | New York, NY |
| Lawrence R Lamb | Executive Officer | New York, NY |
| Patrick McCall | Executive Officer | New York, NY |
| Kate R Rochlin | Executive Officer | New York, NY |
| Travis R Whitfill | Director | New York, NY |
| Emily S Fairbairn | Director | New York, NY |
| Trishna R Goswami | Executive Officer | New York, NY |
| Travis Whitfill | Director | Hummelstown, PA |
| Melissa Beelen | Executive Officer | New York, NY |
| Thomas Cirrito | Director | New York, NY |
| Larry Lamb | Executive Officer | New York, NY |
| Peter Brandt | Director | New York, NY |
Other filings by this issuer (5)
More